Abstract:The piggyBac transposon system is a promising nonviral method to genetically modify T cells for immunotherapeutic applications. To evaluate the regulation and stability of transgene expression in human T cells modified with piggyBac-transposons, peripheral blood mononuclear cells were nucleofected with transposase and an enhanced green fluorescence protein (eGFP)-expressing transposon. Single-cell clones that were subsequently stimulated and expanded exhibited homogenous eGFP expression for >26 weeks in culture. CD3 stimulation of the T-cell receptor together with CD28-mediated costimulation resulted in an approximate 10-fold transient increase in eGFP expression, but immunomodulatory cytokines, including interferon-γ, interleukin-12, interleukin-4, and transforming growth factor-β, did not alter transgene expression in actively dividing, activated, or resting T cells. Epigenetic modification with 5-azacytidine or trichostatin-A increased transgene expression indicating that piggyBac-mediated transgene expression could be modulated by methylation or histone acetylation, respectively. We performed transposon copy number analysis of populations of stably transfected T cells, comparing transposon plasmids of 5.6 and 3.5 kb. The smaller vector achieved an average of 22 transposon copies per cell, whereas the larger vector achieved 1.6 copies/cell, implying that transposon copy number can be engineered to be low or high depending on the vector used. Our results provide important insight into the ability of piggyBac to achieve stable genetic modification of T cells for immunotherapy applications and how transgene expression might be regulated by TCR activation, cytokines, and epigenetic mechanisms.

Hyperactive Piggybac Gene Transfer in Human Cells and in Vivo

A Transgenic Bm Cell Line of Piggybac Transposon-Derived Targeting Expression of Humanized Glycoproteins Through N-glycosylation.

[The Improvement and Application of Piggybac Transposon System in Mammals].

Using Chimeric Piggybac Transposase to Achieve Directed Interplasmid Transposition in Silkworm Bombyx Mori and Fruit Fly Drosophila Cells

A Nucleolus-Predominant piggyBac Transposase, NP-mPB, Mediates Elevated Transposition Efficiency in Mammalian Cells

RNA-guided piggyBac transposition in human cells

Piggybac Transposon Vectors: the Tools of the Human Gene Encoding

piggyBac as a high-capacity transgenesis and gene-therapy vector in human cells and mice.

An efficient Screening System in Yeast to Select a Hyperactive piggyBac Transposase for Mammalian Applications

Application of PiggyBac Transposon in Mammals

Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes

TAL Effectors Mediate High-Efficiency Transposition of the Piggybac Transposon in Silkworm Bombyx Mori L

A Modified Piggybac Transposon System Mediated by Exogenous Mrna to Perform Gene Delivery in Bovine Mammary Epithelial Cells

DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors

Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.

An optimized polymeric delivery system for piggyBac transposition

piggyBac transposase tools for genome engineering

Application of PiggyBac in Transgenic Mice

PiggyBac Transposon Mediated Efficient Egfp Expression in Porcine Somatic Cells and Cloned Embryos

Transposase N-terminal phosphorylation and asymmetric transposon ends inhibit piggyBac transposition in mammalian cells

In Vivo Piggy bac-Based Gene Delivery towards Murine Pancreatic Parenchyma Confers Sustained Expression of Gene of Interest